InhaTarget Therapeutics is Drug Discovery in Belgium that focus on systemic treatments business. Founded in 2018. They cover business area such as developer, an inhalable powdered medicine, lung cancer treatment, a dry powder, inhalation, localized treatment, systemic treatment, patient, access, severe and chronic respiratory disease.
2018
( 6 years old in 2024 )
Systemic Treatments
-
Université libre de Bruxelles (ULB), Unité de Pharmacie galénique et de biopharmaci
Campus de la Plaine CP 207 Boulevard du Triomphe
1050 Brussels
Belgium
Private
developeran inhalable powdered medicinelung cancer treatmenta dry powderinhalationlocalized treatmentsystemic treatmentpatientaccesssevere and chronic respiratory disease
* We use standard office opening hours in near InhaTarget Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
InhaTarget Therapeutics is Drug Discovery business from Belgium that founded in 2018 (6 years old in 2024), InhaTarget Therapeutics business is focusing on Systemic Treatments.
InhaTarget Therapeutics headquarter office and corporate office address is located in Université libre de Bruxelles (ULB), Unité de Pharmacie galénique et de biopharmaci Campus de la Plaine CP 207 Boulevard du Triomphe 1050 Brussels Belgium.
InhaTarget Therapeutics was founded in Belgium.
In 2024, InhaTarget Therapeutics is currently focus on systemic treatments sector.
Above is snippet of Google Trends for "systemic treatments" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with InhaTarget Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
